InMode Releases Fourth Quarter and Full Year 2025 Financial Performance Results with GAAP Revenue Trends

InMode Reports Fourth Quarter and Full Year 2025 Financial Results



InMode Ltd., a prominent leader in innovative medical technologies, recently published its financial results for both the fourth quarter and the entire fiscal year of 2025. The figures reveal a landscape marked by both challenges and opportunities, particularly in differing regional markets.

Financial Highlights from Q4 2025


For the fourth quarter of 2025, InMode reported a GAAP revenue of $103.9 million, up from $97.9 million recorded in Q4 2024. This performance reflects a 6% increase, primarily driven by a 21.5 million revenue from consumables and services, marking an 8% growth year-over-year in this segment. Operating income for the quarter stood at $26 million, while non-GAAP operating income was slightly higher at $28.5 million. As of December 31, 2025, the company reported a robust total cash position, totaling $555.3 million, consolidating cash equivalents, marketable securities, and short-term deposits.

Full Year 2025 Financial Summary


The full year results depict a different trend, with total revenues declining to $370.5 million, showing a 6% drop from $394.8 million in 2024. Notably, revenues from consumables and services did see a modest increase, reaching $81.4 million, illustrating growth amidst overall revenue contractions. GAAP operating income for the whole year was reported at $85.4 million, a notable decline compared to $112.5 million in 2024. Non-GAAP operating income was more favorable at $96.5 million, emphasizing a performance contraction across various metrics when compared year-on-year.

Guidance and Outlook for 2026


President Michael Dennison indicated that the North American operations are successfully unified, allowing InMode to effectively serve its customers. Looking forward, the management anticipates launching two innovative laser platforms in 2026, addressing customer demand and enhancing market presence. Forecasts suggest revenues may hover between $365 million to $375 million, with expectations of non-GAAP earnings between $1.43 to $1.48 per diluted share.

Management's Perspective


CEO Moshe Mizrahy expressed cautious optimism about stabilization signs in the market, especially regarding European operations, which saw record revenue in the fourth quarter, underscoring strong performance and execution from regional teams. The company also executed a substantial capital return of $127.4 million to shareholders via stock repurchase schemes.

Yair Malca, CFO, elaborated on the financial strategies in place to navigate the fluctuating economic climate. InMode continues to analyze market demands closely, adapting strategies to concrete developments in international markets to ensure sustained growth. Notably, the geopolitical climate remains a critical backdrop for the company’s operational strategies, particularly in Israel, as it navigates through ongoing complexities stemming from regional conflicts that have developed recently.

Conclusion


InMode's fourth-quarter and full-year financial results signal a period of adaptation amidst shifting market dynamics. The strategic actions outlined by management show intent to pivot towards future growth, with innovative product launches and a renewed focus on operational efficiency. Investors will be keenly watching as the company navigates 2026 with a revitalized approach, striving for stability in revenues and commitment to shareholder returns.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.